Erzofri on BlueMedicare Value Rx (S5795-003)
paliperidone palmitate
Covered.
Tier 4 (non-preferred drug). Quantity limit of 0.25 per 28 days.
$253.00
Patient pays / month, after deductible
$658.90
Patient pays / month, before the $615.00 deductible
$759.01
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
ERZOFRI EXTENDED-RELEASE 39 mg/.25mL Injection at a preferred retail pharmacy, from the plan's negotiated price of $744.13 for a month. Other covered strengths are listed below.
All 6 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| ERZOFRI EXTENDED-RELEASE 117 mg/.75mL Injection | 4 | $749.70 | 0.75 per 28 days |
| ERZOFRI EXTENDED-RELEASE 156 mg/mL Injection | 4 | $937.15 | 1 per 28 days |
| ERZOFRI EXTENDED-RELEASE 234 mg/1.5mL Injection | 4 | $1,874.26 | 1.5 per 28 days |
| ERZOFRI EXTENDED-RELEASE 351 mg/2.25mL Injection | 4 | $346.74 | 4.5 per 365 days |
| ERZOFRI EXTENDED-RELEASE 39 mg/.25mL Injection | 4 | $253.00 | 0.25 per 28 days |
| ERZOFRI EXTENDED-RELEASE 78 mg/.5mL Injection | 4 | $506.03 | 0.5 per 28 days |
Verify with the plan before prescribing or filling. Member services: (844)280-5833. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5795-003